Webcasts: ISBT Macao 2008 Symposium

Cerus Symposium: ISBT 2008 Programme and Webcast Videos (NOTE: each video will open a new browser window.)
Click to View	Presentation/Title
	Dr. Paul Holland (see bio below) Pathogen Inactivation: the Paradigm Shift in Transfusion Medicine
	Dr. Jean-Pierre Cazenave (see bio below) The European Experience: INTERCEPT Platelets and Plasma in Routine Use
	Dr. Mickey Koh (see bio below) Defence Against Emerging Pathogens: Potential Impact of Pathogen Inactivation on Blood Safety and Supply
	Dr. Jeffrey McCullough (see bio below) The Comprehensive Potential of Pathogen Inactivation

THE PRESENTERS

Dr. Paul Holland
UC Davis Medical Center, California, USA

Paul V. Holland, M.D. has been involved in blood banking and transfusion medicine since 1963. He spent over 20 years at the National Institutes of Health in the Blood Bank Department of the Clinical Center, where for the last 9 years he was Chief. Dr. Holland was the Medicial Director and CEO of the Sacramento Medical Foundation Blood Center, currently dba BloodSource, from 1983-2004. He has been a Clinical Professor of Medicine in the Division of Hematology/Oncology at UC Davis Medical Center (UCDMC) since 1983 and is now also a Clinical Professor of Pathology.

Dr. Holland has published over 250 papers in peer reviewed scientific journals. He is currently Scientific Director of Delta Blood Bank in Stockton, California where he continues to be involved in research activities.

Dr. Holland has served on numerous AABB committees, been an advisor to U.S government committees and agencies, and consulted with many biotech companies, foreign governments, and international organizations. Among these are his services on a World Health Organization (WHO) committee to assist blood banks in third world countries, completing two years as President of the International Society of Blood Transfusion, and being a member of the nominating committee for the Nobel Prize in Medicine and Physiology for 3 years.

Dr. Jean-Pierre Cazenave
EFS-Alsace, Strasbourg, France

Jean-Pierre Cazenave was born in L’Aigle, France, on May 6th 1943. He studied medicine at the School of Medicine of Caen, Normandy, France. He was a Resident in hematology at Strasbourg University Hospital and obtained is MD degree in 1970 at the University Louis Pasteur of Strasbourg.

He moved to Canada where he lived for 8 years. He joined the research group of Professor J.F. Mustard at Mac Master University, Hamilton, Ontario, where he worked on platelet physiology and pharmacology. He obtained a PhD degree and was apointed Assistant Professor of Pathology.He returned to Strasbourg, France in 1978 at the Blood Transfusion Center. He created an INSERM research unit in 1986 devoted to the Biology and Pharmacology of Hemostasis and Thrombosis. Since 1987, he has been the Director of the Blood Transfusion Center in Strasbourg.

He has more recently devoted his research to experimental models of platelet transfusion and to clinical studies of pathogen inactivation of blood components.

He is Professor of Hematology and Transfusion at University Louis Pasteur, Faculty of Medicine of Strasbourg, member of several international societies and author of 500 publications.

He has been elected as corresponding member (3rd Division, Biological Sciences) of the Académie Nationale de Médecine. Paris, February 22, 2005.

Dr. Mickey Koh
Health Sciences Authority, Singapore

Dr. Mickey Koh is Deputy Director, Centre for Transfusion Medicine & Medical Director, Cell Therapy Laboratory, Health Sciences Authority, and Singapore. Dr. Koh has also served as a World Health Organization Advisor for Transfusion Medicine, Western Pacifi c Region. Prior to joining the Centre for Transfusion Medicine, he received his PhD from the University of London in 2000 and has held a variety of positions in the UK including Lecturer at the Royal Free Campus, University College Hospital.

Dr. Koh has been an invited speaker at many regional and international conferences including the American Association of Blood Banks Annual Meeting, Sri Lankan Hematology & Blood Banking Conference, ISBT International Congress, World Health Organization Clinical Transfusion Medicine Course, and International Society of Hematology, among others. He is also on the editorial board for the Hematology/Oncology and Stem Cell Therapy journal and is part of the working group developing the National Guidelines and Regulation for Cell Therapy in Singapore.

Dr. Koh’s current research includes studies in the field of acute leukemia and cellular therapy, prevention of GvHD in allogenic stem cell transplantation, and pathogen inactivation of blood components.

Dr. Jeffrey McCullough
University of Minnesota, Minnesota, USA

Jeffrey McCullough, M.D., is Professor of Laboratory Medicine and Pathology; Director of the Biomedical Engineering Institute; and American Red Cross Chair, Transfusion Medicine at the University of Minnesota. Dr. McCullough led the University of Minnesota Hospital Blood Bank in developing and implementing novel blood components and transfusion strategies, conducted an active research program in transfusion medicine and have been responsible for training more than 70 physicians who specialize in transfusion medicine. He served as Editor of Transfusion, the world’s leading blood banking and transfusion medicine journal for 15 years and is author or co-author of approximately 250 scientific and medical publications and has authored his own textbook “Transfusion Medicine”.

Currently, Dr McCullough’s research is focused on cellular engineering for the production of novel blood products, and clinical trials of novel blood transfusion products or strategies.

A native of Boston, Massachusetts, Dr. McCullough received a B.A. degree from Northwestern University in Evanston, Illinois, and an M.D. from Ohio State University in Columbus. He received postgraduate medical training at Vanderbilt University and the University of Minnesota and has studied on sabbatical at the National Heart, Lung, and Blood Institute.